ES2052911T3 - Tableta masticable. - Google Patents

Tableta masticable.

Info

Publication number
ES2052911T3
ES2052911T3 ES89304248T ES89304248T ES2052911T3 ES 2052911 T3 ES2052911 T3 ES 2052911T3 ES 89304248 T ES89304248 T ES 89304248T ES 89304248 T ES89304248 T ES 89304248T ES 2052911 T3 ES2052911 T3 ES 2052911T3
Authority
ES
Spain
Prior art keywords
chewable tablet
therapeutically active
weight
tablet
examples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89304248T
Other languages
English (en)
Inventor
Gordon France
Graham Stanley Leonard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88304008A external-priority patent/EP0294933B1/en
Priority claimed from GB888820265A external-priority patent/GB8820265D0/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Application granted granted Critical
Publication of ES2052911T3 publication Critical patent/ES2052911T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UNA COMPOSICION EN PASTILLA MASTICABLE FARMACEUTICA CONSTA DE: (I) GRANULOS QUE CONTIENEN UNA SUSTANCIA TERAPEUTICAMENTE ACTIVA; Y (II) UN ESCIPIENTE HIGROSCOPICO INSOLUBLE EN AGUA EXTRAGRANULAR EN CANTIDAD DE 5-15 % EN PESO DEL PESO TOTAL DE LA PASTILLA. SUSTANCIAS TERAPEUTICAMENTE ACTIVAS ESPECIALES INCLUYEN CIMETIDINA, Y EJEMPLOS DE EXCIPIENTES HIGROSCOPICOS ADECUADOS SON CELULOSA MICROCRISTALINA Y CELULOSA EN POLVO.
ES89304248T 1988-05-04 1989-04-27 Tableta masticable. Expired - Lifetime ES2052911T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88304008A EP0294933B1 (en) 1987-05-08 1988-05-04 Pharmaceutical compositions
GB888820265A GB8820265D0 (en) 1988-08-26 1988-08-26 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2052911T3 true ES2052911T3 (es) 1994-07-16

Family

ID=26116144

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89304248T Expired - Lifetime ES2052911T3 (es) 1988-05-04 1989-04-27 Tableta masticable.

Country Status (14)

Country Link
EP (1) EP0349103B1 (es)
JP (1) JP2635407B2 (es)
KR (1) KR890016963A (es)
AT (1) ATE82680T1 (es)
AU (1) AU620866B2 (es)
DE (1) DE68903605T2 (es)
DK (1) DK214689A (es)
ES (1) ES2052911T3 (es)
GR (1) GR3006498T3 (es)
IE (1) IE62728B1 (es)
MY (1) MY104010A (es)
NZ (1) NZ228970A (es)
PH (1) PH25173A (es)
PT (1) PT90466B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
ES2174849T3 (es) * 1992-06-04 2002-11-16 Smithkline Beecham Corp Composiciones farmaceuticas con sabor agradable.
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
HUT72408A (en) * 1993-09-10 1996-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing tablets containing acetyl-salicylic acid
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
AU733032C (en) * 1996-06-14 2002-01-03 Kyowa Hakko Kirin Co., Ltd. Intraorally rapidly disintegrable tablet
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
CA2305179A1 (en) * 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Oral administration preparation
US7842308B2 (en) 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JP2006342188A (ja) 2006-09-28 2006-12-21 Rohto Pharmaceut Co Ltd 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物
ES2668203T3 (es) 2009-12-02 2018-05-17 Adare Pharmaceuticals S.R.L. Microcápsulas de fexofenadina y composiciones que las contienen
JP2013032408A (ja) * 2012-11-22 2013-02-14 Rohto Pharmaceutical Co Ltd 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES412146A1 (es) * 1972-03-11 1976-01-01 Pfizer Procedimiento de obtencion de composiciones para reducir elhabito del tabaco.
NL7311319A (es) * 1972-09-01 1974-03-05
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
CA1229552A (en) * 1984-07-09 1987-11-24 Audley A. Legore Cimetidine compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형

Also Published As

Publication number Publication date
PT90466A (pt) 1989-11-30
GR3006498T3 (es) 1993-06-21
MY104010A (en) 1993-10-30
DK214689A (da) 1989-11-05
AU620866B2 (en) 1992-02-27
EP0349103A1 (en) 1990-01-03
JPH01313420A (ja) 1989-12-18
IE891414L (en) 1989-11-04
PH25173A (en) 1991-03-27
DK214689D0 (da) 1989-05-02
DE68903605T2 (de) 1993-04-01
AU3394689A (en) 1989-11-09
JP2635407B2 (ja) 1997-07-30
PT90466B (pt) 1994-08-31
DE68903605D1 (de) 1993-01-07
NZ228970A (en) 1991-09-25
ATE82680T1 (de) 1992-12-15
IE62728B1 (en) 1995-02-22
KR890016963A (ko) 1989-12-14
EP0349103B1 (en) 1992-11-25

Similar Documents

Publication Publication Date Title
ATE82680T1 (de) Kautablette.
ATE125155T1 (de) Niedrigdosierte getrocknete pharmazeutische präparate.
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
DK555389D0 (da) Farmaceutisk praeparat
MX171191B (es) Composiciones farmaceuticas de glipizida
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE125702T1 (de) Feste, schnell-lösliche arzneimittelzubereitung enthaltend s-(carboxymethyl)-l-cystein und/oder n-acetylcystein.
NO922807L (no) Farmasoeytiske dideoksypurinnukleosid-preparater til oraltbruk
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
NO995127D0 (no) Stabiliserte tibolonblandinger
ATE97572T1 (de) Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe.
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
ATE143805T1 (de) Arzneizubereitung mit hohem gehalt an ibuprofenlysinat
BG94934A (bg) Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество
DK0450123T3 (da) Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium
GB2258397A (en) Pharmaceutical compositions containing amethocaine
DK0560207T3 (da) Præparat til oral anvendelse baseret på ibuprofen
TH14574A (th) สารผสมทางเภสัชกรรม

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 349103

Country of ref document: ES